The problem with blindly relying on charts and technicals to make buy and sell decisions with Scrips is the technical indicators are completely ignorant to the continuously-improving fundamentals. People relying on the Bar Chart "sell" signal will sell at the bottom and miss out on the strong PPS increase as Scrips soon delivers on ALL of the following events: (1) Hong Kong orders of RapiMed; (2) China Mainland product approval followed by a heavy influx of orders from the Mainland; (3) elimination of the unrelenting selling pressure from noteholders and Ironridge; (4) confirmation that all toxic notes were paid; (5) $1M monthly revenues from combined JV and compounding pharmacy businesses with clarification on how those revenues translate to SCRC revenues; cash flow positive). While it is good to keep an eye the technicals, I'm a strong believer that over the longterm it will be the vastly improved fundamentals that will lead the chart higher.